171 related articles for article (PubMed ID: 22076286)
1. Less is more: not "going the distance" and why.
Harris R; Kinsinger LS
J Natl Cancer Inst; 2011 Dec; 103(23):1726-8. PubMed ID: 22076286
[No Abstract] [Full Text] [Related]
2. Speaking for the evidence: colonoscopy vs computed tomographic colonography.
Harris R
J Natl Cancer Inst; 2010 Aug; 102(16):1212-4. PubMed ID: 20651321
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.
Knudsen AB; Lansdorp-Vogelaar I; Rutter CM; Savarino JE; van Ballegooijen M; Kuntz KM; Zauber AG
J Natl Cancer Inst; 2010 Aug; 102(16):1238-52. PubMed ID: 20664028
[TBL] [Abstract][Full Text] [Related]
4. Fecal occult blood testing when colonoscopy capacity is limited.
Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening.
Hayee BH; Chung-Faye G
Clin Med (Lond); 2006; 6(5):453-6. PubMed ID: 17080891
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
[TBL] [Abstract][Full Text] [Related]
8. A comparison of three stool tests for colorectal cancer screening.
Greenwald B
Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
Heresbach D; Chauvin P; Grolier J; Josselin JM
Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
[TBL] [Abstract][Full Text] [Related]
10. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
van Gils P; van den Berg M; van Kranen H; de Wit AG
Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464
[TBL] [Abstract][Full Text] [Related]
11. Which colorectal cancer screening test is best?
Mandel JS
J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
[No Abstract] [Full Text] [Related]
12. [Screening: management after incomplete colonoscopy could be improved].
Becx MC; Al-Toma A
Ned Tijdschr Geneeskd; 2014; 158():A7195. PubMed ID: 24569049
[TBL] [Abstract][Full Text] [Related]
13. Screening and diagnosis for colorectal cancer: present and future.
Labianca R; Merelli B
Tumori; 2010; 96(6):889-901. PubMed ID: 21388049
[TBL] [Abstract][Full Text] [Related]
14. Fecal occult blood testing: best option for colorectal cancer screening in Asia?
Sharma SP
J Natl Cancer Inst; 2008 Aug; 100(15):1056-7. PubMed ID: 18664644
[No Abstract] [Full Text] [Related]
15. Colorectal Cancer Screening: Which Test Is Best?
Inadomi JM
JAMA Oncol; 2016 Aug; 2(8):1001-3. PubMed ID: 27305648
[No Abstract] [Full Text] [Related]
16. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
Beswick L; Ting A; Macrae F; Dowling D; Hair C
Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
[No Abstract] [Full Text] [Related]
17. [Surveillance and cost-effectiveness of colonoscopy in asymptomatic increased risk subjects of colorectal cancer: Ferrara experience].
Matarese V; Pezzoli A; Trevisani L; Boccia S; Brancaleoni M; Simone L; Feo C; Gullini S
Recenti Prog Med; 2004; 95(7-8):352-7. PubMed ID: 15303544
[TBL] [Abstract][Full Text] [Related]
18. Radiology Testing in Population Health.
Rawson JV
Acad Radiol; 2015 Jul; 22(7):805-6. PubMed ID: 25979590
[No Abstract] [Full Text] [Related]
19. The case for population-based screening for colorectal cancer.
Schoen RE
Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
[TBL] [Abstract][Full Text] [Related]
20. Replacing guaiac-based tests with immunochemical tests in colorectal cancer screening.
Schlackman N
Am J Med; 2003 Aug; 115(2):154; author reply 154-5. PubMed ID: 12893403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
